MYOS RENS Technology Rockets On Merger With MedAvail To Penetrate Muscle Health Market

Many businesses dream of penetrating whole markets as their stakeholders usually prefer expansion through a merger or acquisition. Hence, most of the giants lead industries and dictate market prices.

Just yesterday NASDAQ: MYOS was $0.88 with little change in daily trading volume. After the merger with MedAvail, MYOS RENS Technology’s stock becomes attractive to new investors so its daily volume soars to more than 127 million shares.

Penny MYOS could shortly be hot stock and slow rise may occur with an indication of stability in long term growth.

The muscle health market is getting larger while weight loss is still trending as eating in fast food courts and restaurants leads to obesity. MYOS RENS Technology chose the right market which has a high potential in growth.